Product Name:1-(3,5-Difluoro-2-hydroxyphenyl)ethanone

IUPAC Name:1-(3,5-difluoro-2-hydroxyphenyl)ethan-1-one

CAS:140675-42-9
Molecular Formula:C8H6F2O2
Purity:95%+
Catalog Number:CM372874
Molecular Weight:172.13

Packing Unit Available Stock Price($) Quantity
CM372874-5g in stock ȁƀ
CM372874-10g in stock ƦƦŴ
CM372874-25g in stock NJȁȬ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:140675-42-9
Molecular Formula:C8H6F2O2
Melting Point:-
Smiles Code:CC(=O)C1=C(O)C(F)=CC(F)=C1
Density:
Catalog Number:CM372874
Molecular Weight:172.13
Boiling Point:
MDL No:
Storage:

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

STX-478
Scorpion presented initial, first-in-human clinical results from its Phase 1/2 study of STX-478 in advanced solid tumor patients in a Proffered Paper late-breaking session at the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain. Initial Phase 1 monotherapy data for STX-478, an oral, once-daily, mutant-selective, allosteric PI3Kα inhibitor, demonstrated potentially best-in-class PI3Kα inhibition, with anti-tumor activity observed in multiple cancer types, including HR+/HER2- breast cancer (BC), gynecological tumors, and other solid tumors. STX-478 was well-tolerated, including in pre-diabetic, diabetic and heavily pre-treated patients and showed no significant wild-type-mediated toxicities.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.